ATLASATLAS fair value
₹1,669
Close to fair value · 7% premium
Range: ₹1,502–₹1,836Fair valuePrice
Emcure Pharmaceuticals (EMCURE.NSE)
Emcure Pharmaceuticals share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹1,780▲ +0.55%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Emcure Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Emcure Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Emcure Pharmaceuticals's fair value at about ₹1,669 per share (reasonable range: ₹1,502 to ₹1,836). At ₹1,780, the stock trades within 8% of that figure: close to fair value.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Emcure Pharmaceuticals a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,697 and ₹1,876; in 9 out of 10, between ₹1,552 and ₹2,051. Estimated annual volatility is 27%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹335B
- Market cap (USD)
- $3.5B
- P/E ratio
- 33.2
- Dividend yield
- 0.81%
- 52-week high
- ₹2,101
- 52-week low
- ₹1,307
- Revenue (12 months)
- ₹96.8B
- Operating margin
- 15.4%
- Net margin
- 10.4%
- Beta
- -0.08
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Emcure Pharmaceuticals sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks EMCURE.NSE has traded between ₹1,307 and ₹2,101. Today it is 15.3% below that high and 36% above its low.
On the business: net margin is 10.4%; it trades at 33.2 times earnings.
Its beta is -0.08: it tends to move less than the market.
About the company
Emcure Pharmaceuticals Ltd. is a leading pharmaceutical company specializing in the production and distribution of a diverse range of healthcare solutions.
Want to see everything about Emcure Pharmaceuticals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Emcure Pharmaceuticals (EMCURE.NSE) fair value?
About ₹1,669 per share according to ATLAS (reasonable range: ₹1,502 to ₹1,836). With the stock at ₹1,780, it is close to that value.
What is the chance EMCURE.NSE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, EMCURE.NSE ends the month between ₹1,697 and ₹1,876.
How big is Emcure Pharmaceuticals and what is its P/E ratio?
Emcure Pharmaceuticals's market capitalization is ₹335B. Its price-to-earnings (P/E) ratio is 33.2: you pay ₹33.2 for each ₹1.00 of yearly earnings.
Does Emcure Pharmaceuticals pay a dividend?
Yes. EMCURE.NSE's current dividend yield is 0.81% at today's price (₹1,780).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer